Clinical features and sulfonylurea usage among outpatients with diabetes aged ≥90 years in an urban diabetes clinic in Tokyo.

Toshiko KoboriYukiko OnishiYoko YoshidaTazu TaharaTakako KikuchiTetsuya KubotaMasahiko IwamotoShoko HamanoMasato Kasuga

Published in: Journal of diabetes investigation (2022)

Although tapering the dosage of sulfonylurea was attempted in nonagenarian patients, sulfonylurea was widely continued for glycemic control. Reverse clinical inertia may exist in some sulfonylurea-treated nonagenarian patients.

Keyphrases

glycemic control
end stage renal disease
type diabetes
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
primary care
insulin resistance
metabolic syndrome